These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16548784)

  • 1. Combating psychosis in Parkinson's disease patients: the use of antipsychotic drugs.
    Chou KL; Fernandez HH
    Expert Opin Investig Drugs; 2006 Apr; 15(4):339-49. PubMed ID: 16548784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease: the treatment of drug-induced hallucinations and psychosis.
    Molho ES; Factor SA
    Curr Neurol Neurosci Rep; 2001 Jul; 1(4):320-8. PubMed ID: 11898537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis.
    Sa DS; Kapur S; Lang AE
    Clin Neuropharmacol; 2001; 24(4):242-4. PubMed ID: 11479398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review.
    Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D
    J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosis in Parkinson's disease.
    Poewe W
    Mov Disord; 2003 Sep; 18 Suppl 6():S80-7. PubMed ID: 14502660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of psychosis in Parkinson's disease.
    D'Souza C; Gupta A; Alldrick MD; Sastry BS
    Int J Clin Pract; 2003 May; 57(4):295-300. PubMed ID: 12800461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of quetiapine in elderly patients.
    Tariot PN; Ismail MS
    J Clin Psychiatry; 2002; 63 Suppl 13():21-6. PubMed ID: 12562143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of psychosis in Parkinson's disease: safety considerations.
    Fernandez HH; Trieschmann ME; Friedman JH
    Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial.
    Factor SA; Friedman JH; Lannon MC; Oakes D; Bourgeois K;
    Mov Disord; 2001 Jan; 16(1):135-9. PubMed ID: 11215574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
    Abbar M; Courtet P; Castelnau D
    Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
    Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
    Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.
    Factor SA; Molho ES; Brown DL
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):304-7. PubMed ID: 7580188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis].
    Kodama R; Morita S; Miwa H; Kondo T
    No To Shinkei; 2003 May; 55(5):413-7. PubMed ID: 12833883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course, prognosis, and management of psychosis in Parkinson's disease: are current treatments really effective?
    Zahodne LB; Fernandez HH
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):26-33. PubMed ID: 18323764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine for the treatment of psychosis in Parkinson's disease: a review.
    Auzou P; Ozsancak C; Hannequin D; Moore N; Augustin P
    Acta Neurol Scand; 1996 Nov; 94(5):329-36. PubMed ID: 8947285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing psychosis in patients with Parkinson's disease.
    Cummings JL
    N Engl J Med; 1999 Mar; 340(10):801-3. PubMed ID: 10072418
    [No Abstract]   [Full Text] [Related]  

  • 17. Clozapine in drug-induced psychosis in Parkinson's disease. The French Clozapine Parkinson Study Group.
    Lancet; 1999 Jun; 353(9169):2041-2. PubMed ID: 10376627
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychosis of Parkinson's disease: serotonin 2A receptor inverse agonists as potential therapeutics.
    Weiner DM; Vanover KE; Brann MR; Meltzer HY; Davis RE
    Curr Opin Investig Drugs; 2003 Jul; 4(7):815-9. PubMed ID: 14619402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment.
    van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
    Eur J Clin Pharmacol; 2002 May; 58(2):157-61. PubMed ID: 12012150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson disease psychosis: Update.
    Friedman JH
    Behav Neurol; 2013 Jan; 27(4):469-77. PubMed ID: 23242358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.